February 1983

Massive Hemoptysis in Cystic Fibrosis

Author Affiliations

From the Pulmonary Disease Service, Department of Medicine (Drs Porter and Anthracite), and the Department of Surgery (Drs Van Every and Mack), Wilford Hall USAF Medical Center (AFSC), Lackland AFB, Tex.

Arch Intern Med. 1983;143(2):287-290. doi:10.1001/archinte.1983.00350020113021

• Massive hemoptysis occurs in 5% to 7% of patients with cystic fibrosis. Approximately 11% of these patients will die within 48 hours of manifestation because of uncontrolled hemoptysis and asphyxiation. If conservative medical treatment fails to control hemoptysis, fiberoptic or rigid bronchoscopy is the least risky and most accurate method of localizing the source of hemoptysis. Acute control of hemoptysis can be obtained in up to 100% of patients with endobronchial Fogarty balloon tamponade and in up to 88% of patients with bronchial artery embolization. Emergency thoracotomy can be performed if the above fail, but only in patients with mild cystic fibrosis and adequate pulmonary reserve.

(Arch Intern Med 1983;143:287-290)